YK11

1370003-76-1

C25H34O6

DMSO : >= 64 mg/mL (148.65 mM)

Others

YK11 is a partial agonist of androgen receptor, with osteogenic activity. IC50 & Target: Androgen receptor^[1] In Vitro: YK11 is a partial agonist of androgen receptor, and induces myogenic differentiation of C2C12 Cells at 500 nM via Fst mRNA upregulation by AR. YK11 enhances Myf5 and myogenin mRNA expression, but requires high concentrations (YK11, 100?nM or 500?nM)^[1]. YK11 (0.5?uM) increases the cell growth of osteoblastic MC3T3-E1 cells, and enhances ALP activity via AR. YK11 also elevates osteoprotegerin mRNA expression (0.5?uM) and dose-dependently increases osteocalcin mRNA expression (0.1-1.0 uM). In addition, YK11 enhances phosphorylation of Akt protein via rapid non-genomic signaling^[2].